Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014980 220009600 null null Disease modification (D) 2014-10-10 2014-10-15 ALEMTUZUMAB + FLUDARABINE N N 220036542 DACARBAZINE
220014981 220015086 null 72.5 Palliative (P) 2014-02-14 2014-02-28 BENDAMUSTINE + RITUXIMAB null null 220036543 MITOXANTRONE + TRETINOIN
220014984 220009604 1.64 64.1 Curative (C) 2014-06-13 2014-09-19 Alemtuzumab + Cyclophos TBI Allo null N 220036557 BUSULPHAN
220014985 220015089 1.7 92 Palliative (P) 2015-10-03 2016-11-02 CETUXIMAB + IRINOTECAN + MDG N N 220036560 CAPECITABINE + OXALIPLATIN
220014986 220009605 1.82 94.2 Palliative (P) 2017-10-12 2017-10-12 Ipilimumab N N 220036563 LENALIDOMIDE
220014987 220009608 1.6 60 Disease modification (D) 2014-01-10 2014-01-12 CAV N N 220036563 CAV
220014988 220018228 1.62 70.8 Curative (C) 2018-03-20 2018-04-06 Arsenic Triox + Tretinoin Ind W1-4 N N 220036566 CYCLOPHOSHAMIDE
220014989 220018228 1.65 44.4 Curative (C) 2013-11-04 2013-11-22 Ipilimumab 2 N 220036566 PEMBROLIZUMAB
220014990 220009611 1.67 null Disease modification (D) 2017-05-29 2017-05-30 EEF or EOF N N 220036577 ETOPOSIDE
220014991 220009611 1.77 96.1 Disease modification (D) 2015-02-26 2015-04-18 EOX N N 220036577 CISPLATIN
220014992 220009613 1.62 65.6 Curative (C) 2016-03-14 2016-03-15 Bortezomib +/- Dexamethasone null null 220036590 IPILIMUMAB
220014993 220009615 1.67 58.4 Palliative (P) 2015-11-26 2015-12-01 MPT 02 null 220036594 IPILIMUMAB
220014995 220009617 null 69.8 Palliative (P) 2013-04-26 2013-09-30 FLUDARABINE 02 null 220036606 BUSULFAN + CYCLOPHOSPHAMIDE
220014997 220009623 1.58 52.5 Adjuvant (A) 2015-10-02 2015-10-09 Cisplatin + Etoposide (3 day) N N 220036614 PEMBROLIZUMAB
220014998 220009627 1.75 90.5 Palliative (P) 2012-10-02 2012-10-10 Sunitinib N N 220036619 AFATINIB
220014999 220009628 1.73 67.6 Palliative (P) 2017-08-05 2017-08-16 CYTARABINE + MITOXANTRONE N N 220036629 CAPECITABINE
220015000 220009632 1.63 null Palliative (P) 2014-09-29 2014-09-29 DHAP - R N N 220036632 CLADRIBINE + CYTARABINE + DAUNORUBICIN
220015001 220009634 1.62 67.5 Palliative (P) 2017-02-03 2017-04-24 LENALIDOMIDE N N 220036633 CAPECITABINE + OXALIPLATIN
220015002 220009637 1.49 55 Palliative (P) 2013-04-11 2015-10-06 RAVVA TRIAL 2 N 220036640 CETUXIMAB + RT
220015003 220009639 0 70.6 Palliative (P) 2013-09-22 2014-09-25 BUSULFAN + CYCLO N N 220036641 RAVVA TRIAL
220015004 220009647 1.66 65 Palliative (P) 2017-04-27 2017-04-28 Venetoclax N N 220036653 CAV
220015005 220015095 1.56 66.8 Palliative (P) 2015-01-18 2015-03-07 CISPLATIN + RT 02 N 220036654 CYCLOPHOSPHAMIDE HIGH DOSE
220015006 220009650 1.64 70.5 Palliative (P) null 2017-12-21 Cyclophosphamide High Dose 02 N 220036659 IPILIMUMAB
220015007 220009651 1.32 null Palliative (P) 2017-10-15 2017-10-15 Capecitabine 99 N 220036663 CVAD
220015009 220009654 1.72 112.7 Curative (C) 2016-06-17 2016-06-24 IPILIMUMAB + NIVOLUMAB 2 N 220036669 EOX
220015010 220015097 1.65 88.65 null 2014-02-14 2014-02-14 Gemcitabine 1000mg/m2 D1 8 15 N N 220036673 CLOFARABINE + CYTSARABINE + IDARUBICIN
220015011 220015097 1.6 44.8 Curative (C) null 2018-01-09 Venetoclax N N 220036673 IPILIMUMAB + NIVOLUMAB
220015012 220009657 null 45 Neo-adjuvant (N) 2018-01-01 2018-01-01 Bendamustine+Rituximab (1st Course) null null 220036675 EC
220015013 220009658 1.73 108.5 Palliative (P) 2015-03-24 2015-05-22 NIVOLUMAB N N 220036681 MA
220015014 220009659 1.72 63.9 Not known (9) 2015-01-20 2015-01-20 ECarboX 2 N 220036683 EOX
220015015 220009661 null 72.5 Curative (C) 2015-07-30 2015-07-31 CYTARABINE + MITOXANTRONE 1 N 220036683 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220015016 220009661 1.78 76.6 Palliative (P) 2017-10-20 2018-01-08 Gemcitabine 1000mg/m2 D1 8 15 N Y 220036683 TOPOTECAN
220015017 220009662 1.9 112 Curative (C) 2016-06-29 2016-06-29 CHOP R - 21 days N N 220036703 CISPLATIN + FLUOROURACIL
220015018 220009663 1.67 null Palliative (P) 2014-03-04 2014-03-04 GEMCITABINE N null 220036716 FCR
220015019 220009664 1.59 68 Palliative (P) 2018-01-30 2017-10-17 PACLITAXEL + TRASTUZUMAB 01 N 220036717 CISPLATIN + VINORELBINE
220015020 220015102 1.83 73.6 Palliative (P) 2018-02-08 2018-05-05 CAPECITABINE + GEMCITABINE N N 220036725 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220015021 220015102 1.76 78.3 Not known (9) 2017-11-26 2017-11-30 Temozolomide 150mg/m2 02 N 220036725 PEMBROLIZUMAB
220015022 220009665 1.63 52.5 Palliative (P) 2016-05-06 2016-05-22 Ipilimumab N Y 220036729 CISPLATIN
220015023 220009666 1.8 null Palliative (P) 2017-11-28 2017-12-05 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB 2 null 220036730 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220015024 220015103 1.77 87.1 Palliative (P) null 2015-02-06 Ipilimumab N N 220036733 CISPLATIN + METHOTREXATE + VINCRISTINE
220015025 220009668 1.74 null Palliative (P) 2013-12-06 2013-12-06 BUSULFAN + CYCLO N null 220036733 IPILIMUMAB
220015027 220009672 1.71 66.8 Palliative (P) 2015-01-12 2015-01-17 Sorafenib 02 N 220036742 CISPLATIN + DOCETAXEL + FLUOROURACIL
220015028 220009672 1.65 65 Palliative (P) 2017-08-02 2017-08-08 Irinotecan N N 220036742 MERCAPTOPURINE + METHOTREXATE
220015029 220015106 1.6 null Palliative (P) 2012-07-15 2013-04-02 Carboplatin AUC 6 - 10 02 N 220036755 CAV
220015030 220015107 0 null Disease modification (D) 2016-12-13 2017-01-13 MACE 2 N 220036757 CISPLATIN
220015031 220015107 null null Palliative (P) 2014-12-11 2014-12-14 Abiraterone N N 220036757 MITOXANTRONE + TRETINOIN
220015032 220009676 null 18 Curative (C) null 2018-01-03 BENDAMUSTINE + RITUXIMAB null N 220036760 FIGARO TRIAL
220015033 220009677 0 106.2 Curative (C) 2014-10-21 2014-10-30 Cetuximab 7 day (Cycle 1) N N 220036760 CISPLATIN + ETOPOSIDE
220015034 220009678 1.65 48 Not known (9) 2016-01-08 2016-02-05 Bevacizumab 5mg/kg N N 220000626 BUSULFAN + CYCLOPHOSPHAMIDE
220015035 220009679 1.75 76.8 Palliative (P) 2013-08-02 2013-08-02 Erlotinib N N 220000653 CISPLATIN + FLUOROURACIL